Close
Help
Need Help?





JOURNAL

Clinical Medicine Insights: Dermatology

143,694 Journal Article Views | Journal Analytics

Anti-Inflammatory Properties of Clindamycin: A Review of Its Use in the Treatment of Acne Vulgaris

Submit a Paper



Publication Date: 28 Aug 2011

Type: Review

Journal: Clinical Medicine Insights: Dermatology

Citation: Clinical Medicine Insights: Dermatology 2011:4 27-41

doi: 10.4137/CMD.S5058

Abstract

Topical clindamycin is a safe and effective treatment in mild to moderately-severe inflammatory acne vulgaris. Although clindamycin monotherapy often results in significant clinical improvement, clindamycin combination therapy with either benzoyl peroxide or a retinoid offers most patients a higher level of efficacy in the treatment of acne. This paper reviews the clinical efficacy and safety of clindamycin monotherapy and combination therapies, as well as an investigation into bacterial resistance against clindamycin.


Downloads

PDF  (572.97 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)


Sharing




What Your Colleagues Say About Clinical Medicine Insights: Dermatology
I highly recommend publication in Libertas Academia journals. The entire submission, review and publication process for our article in Clinical Medicine Insights: Dermatology was easy and quick.  The reviews were very professional and helpful and the publication fees were reasonable.  We also appreciate that our article is available online free of charge to anyone interested in it.
Dr Lisa Roche (New Jersey Department of Health and Senior Services, Trenton, NJ, USA)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results